DETROIT / Aug 23, 2023 / Business Wire / UnitedHealthcare Community Plan of Michigan awarded five federally qualified health centers (FQHCs) $100,000 grants to expand access to behavioral health services across the state. The FQHCs include Cherry Health, Family Health Center, Great Lakes Bay Health Centers, InterCare Community Health Network and MidMichigan Community Health Services.
“Our FQHC partners work tirelessly to ensure individuals in the communities we serve are able to obtain critical care like behavioral health support,” said Dennis Mouras, CEO, UnitedHealthcare Community Plan of Michigan. “It is an honor to collaborate with them to ensure Michiganders receive the services they need to support their mental health.”
Each of the FQHCs have dedicated the grant funds to specific projects:
“We are very appreciative of the support from UnitedHealthcare, which will help us improve the lives of all of our patients," said Eileen Chiang, vice president of corporate services and CFO, Family Health Center. “We continue to focus on refining our services to ensure that we are meeting the needs of our patients. As part of these efforts, the grant is helping us advance behavioral health and substance use services for community members in Kalamazoo County.”
Nearly 30% of adults in Michigan report experiencing symptoms related to anxiety or depression. Many people in need of behavioral health care or substance use treatment are unable to access it in a timely manner due to provider shortages, particularly in rural areas. The grant recipients recognize that there is a need to increase access to care and deploy innovative programs to drive better behavioral health outcomes in Michigan.
“Through the generous grant provided by UnitedHealthcare we have been able to implement training for all of our mental health providers in suicide screening and assessment and started new psychosocial groups at the organization’s largest site in Benton Harbor,” said David Gamble, director of behavioral health and SUD services, InterCare Community Health Network. “Additionally, we are making plans to invest in recruitment and retention, as well as technology, to improve our workforce capacity and efficiency to provide the level of access that will meet the needs of the communities we serve.”
UnitedHealthcare serves more than 1.7 million members enrolled in Medicaid, employer-sponsored, individual and Medicare and retirement plans in Michigan, with a network of 156 hospitals, and over 55,000 physicians and other care providers statewide.
About UnitedHealthcare
UnitedHealthcare is dedicated to helping people live healthier lives and making the health system work better for everyone by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. In the United States, UnitedHealthcare offers the full spectrum of health benefit programs for individuals, employers, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1.6 million physicians and care professionals, and 8,000 hospitals and other care facilities nationwide. The company also provides health benefits and delivers care to people through owned and operated health care facilities in South America. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified health care company. For more information, visit UnitedHealthcare at www.uhc.com or follow UnitedHealthcare on LinkedIn.
Last Trade: | US$500.70 |
Daily Change: | 11.45 2.34 |
Daily Volume: | 9,403,075 |
Market Cap: | US$460.780B |
October 15, 2024 July 16, 2024 May 23, 2024 September 12, 2023 August 17, 2023 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB